349 related articles for article (PubMed ID: 11313997)
21. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis.
Yamada T; Takaoka AS; Naishiro Y; Hayashi R; Maruyama K; Maesawa C; Ochiai A; Hirohashi S
Cancer Res; 2000 Sep; 60(17):4761-6. PubMed ID: 10987283
[TBL] [Abstract][Full Text] [Related]
22. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.
Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y
Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585
[TBL] [Abstract][Full Text] [Related]
23. Rare activation of the TCF/beta-catenin pathway in ovarian cancer.
Furlong MT; Morin PJ
Gynecol Oncol; 2000 Apr; 77(1):97-104. PubMed ID: 10739697
[TBL] [Abstract][Full Text] [Related]
24. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
25. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin.
Bordonaro M; Mariadason JM; Aslam F; Heerdt BG; Augenlicht LH
Cell Growth Differ; 1999 Oct; 10(10):713-20. PubMed ID: 10547075
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.
Nath N; Kashfi K; Chen J; Rigas B
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12584-9. PubMed ID: 14566053
[TBL] [Abstract][Full Text] [Related]
27. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
de la Taille A; Rubin MA; Chen MW; Vacherot F; de Medina SG; Burchardt M; Buttyan R; Chopin D
Clin Cancer Res; 2003 May; 9(5):1801-7. PubMed ID: 12738737
[TBL] [Abstract][Full Text] [Related]
28. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
Chen RH; McCormick F
Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074
[TBL] [Abstract][Full Text] [Related]
29. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin.
Kawasoe T; Furukawa Y; Daigo Y; Nishiwaki T; Ishiguro H; Fujita M; Satoh S; Miwa N; Nagasawa Y; Miyoshi Y; Ogawa M; Nakamura Y
Cancer Res; 2000 Jul; 60(13):3354-8. PubMed ID: 10910037
[TBL] [Abstract][Full Text] [Related]
31. Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer.
Dimberg J; Hugander A; Sirsjö A; Söderkvist P
Anticancer Res; 2001; 21(2A):911-5. PubMed ID: 11396184
[TBL] [Abstract][Full Text] [Related]
32. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.
Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K
J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551
[TBL] [Abstract][Full Text] [Related]
33. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation.
Takada Y; Bhardwaj A; Potdar P; Aggarwal BB
Oncogene; 2004 Dec; 23(57):9247-58. PubMed ID: 15489888
[TBL] [Abstract][Full Text] [Related]
34. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
Sasaki T; Suzuki H; Yagi K; Furuhashi M; Yao R; Susa S; Noda T; Arai Y; Miyazono K; Kato M
Cancer Res; 2003 Feb; 63(4):801-6. PubMed ID: 12591729
[TBL] [Abstract][Full Text] [Related]
35. Galectin-3, a novel binding partner of beta-catenin.
Shimura T; Takenaka Y; Tsutsumi S; Hogan V; Kikuchi A; Raz A
Cancer Res; 2004 Sep; 64(18):6363-7. PubMed ID: 15374939
[TBL] [Abstract][Full Text] [Related]
36. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
Takahashi M; Nakamura Y; Obama K; Furukawa Y
Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas.
Fujita M; Furukawa Y; Tsunoda T; Tanaka T; Ogawa M; Nakamura Y
Cancer Res; 2001 Nov; 61(21):7722-6. PubMed ID: 11691783
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effect of aspirin in glioblastoma cells by modulation of β-catenin/T-cell factor-mediated transcriptional activity.
Lan F; Yue X; Han L; Yuan X; Shi Z; Huang K; Yang Y; Zou J; Zhang J; Jiang T; Pu P; Kang C
J Neurosurg; 2011 Oct; 115(4):780-8. PubMed ID: 21721879
[TBL] [Abstract][Full Text] [Related]
39. Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells.
Pradeep A; Sharma C; Sathyanarayana P; Albanese C; Fleming JV; Wang TC; Wolfe MM; Baker KM; Pestell RG; Rana B
Oncogene; 2004 Apr; 23(20):3689-99. PubMed ID: 15116100
[TBL] [Abstract][Full Text] [Related]
40. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
Alves-Guerra MC; Ronchini C; Capobianco AJ
Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]